Terms: = Brain cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2
1680 results:
1. The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant her2-positive breast cancer.
Park M; Jung E; Park JM; Park S; Ko D; Seo J; Kim S; Nam KD; Kang YK; Farrand L; Hoang VH; Nguyen CT; La MT; Nam G; Park HJ; Ann J; Lee J; Kim YJ; Kim JY; Seo JH
Theranostics; 2024; 14(6):2442-2463. PubMed ID: 38646654
[No Abstract] [Full Text] [Related]
2. Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With erbb2-Positive Metastatic Breast cancer.
Frenel JS; Zeghondy J; Guérin-Charbonnel C; Mailliez A; Volant E; Poumeaud F; Patsouris A; Arnedos M; Bailleux C; Cabal J; Galland L; de Nonneville A; Guiu S; Dalenc F; Pistilli B; Bachelot T; Pierga JY; Le Du F; Bocquet F; Larrouquere L; Loirat D
JAMA Netw Open; 2024 Apr; 7(4):e244435. PubMed ID: 38568692
[TBL] [Abstract] [Full Text] [Related]
3. Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with cancer study.
McDeed AP; Van Dyk K; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Nakamura ZM; Rentscher KE; Saykin AJ; Small BJ; Root JC; Jim H; Patel SK; Mcdonald BC; Mandelblatt JS; Ahn J
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38556480
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic stratification ability of the CPS+EG scoring system in her2-low and her2-zero early breast cancer treated with neoadjuvant chemotherapy.
Roussot N; Constantin G; Desmoulins I; Bergeron A; Arnould L; Beltjens F; Mayeur D; Kaderbhai C; Hennequin A; Jankowski C; Padeano MM; Costaz H; Jacinto S; Michel E; Amet A; Coutant C; Costa B; Jouannaud C; Deblock M; Levy C; Ferrero JM; Kerbrat P; Brain E; Mouret-Reynier MA; Coudert B; Bertaut A; Ladoire S
Eur J Cancer; 2024 May; 202():114037. PubMed ID: 38554542
[TBL] [Abstract] [Full Text] [Related]
5. Outcomes of the patients with metastatic male breast cancer.
Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
[TBL] [Abstract] [Full Text] [Related]
6. Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review.
Wallace G; Kundalia R; Vallebuona E; Cao B; Kim Y; Forsyth P; Soyano A; Smalley I; Pina Y
Breast Cancer Res; 2024 Mar; 26(1):55. PubMed ID: 38553702
[TBL] [Abstract] [Full Text] [Related]
7. Human Epidermal Growth Factor Receptor 2-Low Breast cancer brain Metastases: An Opportunity for Targeted Systemic Therapies in a High-Need Patient Population.
Chehade R; Nofech-Mozes S; Plotkin A; Fan KY; Das S; Sahgal A; Moravan V; Jerzak KJ
JCO Precis Oncol; 2024 Mar; 8():e2300487. PubMed ID: 38547418
[TBL] [Abstract] [Full Text] [Related]
8. Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in her2-Positive Breast cancer with brain Metastases.
Wang C; Xiang J; Zhang Q; Li J; Liu Y; Liu J
Drug Des Devel Ther; 2024; 18():909-917. PubMed ID: 38545432
[TBL] [Abstract] [Full Text] [Related]
9. Protecting the brain: Novel Strategies for Preventing Breast cancer brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood-brain Barrier Models.
Kirchner J; Völker E; Shityakov S; Saji S; Förster CY
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542355
[TBL] [Abstract] [Full Text] [Related]
10. Survival Analysis of Male Patients with brain Metastases at Initial Breast cancer Diagnosis over the Last Decade.
Avila J; Leone J; Vallejo CT; Leone JP
Med Sci (Basel); 2024 Mar; 12(1):. PubMed ID: 38535156
[TBL] [Abstract] [Full Text] [Related]
11. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
Strickland MR; Lander EM; Gibson MK; Ilson DH; Ajani JA; Klempner SJ
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38503041
[TBL] [Abstract] [Full Text] [Related]
12. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer.
Borm KJ; Behzadi ST; Hörner-Rieber J; Krug D; Baumann R; Corradini S; Duma MN; Dunst J; Fastner G; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Matuschek C; Piroth MD; Schmeel LC; Souchon R; Strnad V; Budach W; Combs SE;
Strahlenther Onkol; 2024 Apr; 200(4):259-275. PubMed ID: 38488902
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
14. Detection of her2 expression using
Zhao L; Xing Y; Liu C; Ma S; Huang W; Cheng Z; Zhao J
Breast Cancer Res; 2024 Mar; 26(1):40. PubMed ID: 38459598
[TBL] [Abstract] [Full Text] [Related]
15. Impact of the Breast cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry Study.
Sanft TB; Wong J; O'Neal B; Siuliukina N; Jankowitz RC; Pegram MD; Fox JR; Zhang Y; Treuner K; O'Shaughnessy JA
J Natl Compr Canc Netw; 2024 Mar; 22(2):99-107. PubMed ID: 38437792
[TBL] [Abstract] [Full Text] [Related]
16. Bioinformatics analysis reveals multiple functional changes in astrocytes in temporal lobe epilepsy.
Li D; Wang Y; Guo Y; Wang W
Brain Res; 2024 May; 1831():148820. PubMed ID: 38417653
[TBL] [Abstract] [Full Text] [Related]
17. Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis.
Vasseur A; Cabel L; Hego C; Takka W; Trabelsi Grati O; Renouf B; Lerebours F; Loirat D; Brain E; Cottu P; Sablin MP; Pierga JY; Callens C; Renault S; Bidard FC
Oncogene; 2024 Apr; 43(16):1214-1222. PubMed ID: 38413796
[TBL] [Abstract] [Full Text] [Related]
18. Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with her2-enriched breast cancer.
Li Y; Qin J; Chen G; Wu W; Sun X
Int J Clin Oncol; 2024 Apr; 29(4):427-441. PubMed ID: 38411882
[TBL] [Abstract] [Full Text] [Related]
19. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
20. Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes.
Baccili Cury Megid T; Baskurt Z; Ma LX; Barron CC; Farooq A; Saltiel MP; Wang X; Bach Y; Ayoama H; Jang RW; Chen E; Veit-Haibach P; Wang B; Kalimuthu S; Cotton J; Wong R; Mesci A; Elimova E
J Neurooncol; 2024 Mar; 167(1):111-122. PubMed ID: 38372902
[TBL] [Abstract] [Full Text] [Related]
[Next]